Article by Yippee-Ki-Yay

CSG NV Stock Analysis: Buy the Dip or Run for Cover?

Buy signal | Private publication | 13 Sep 2026

CSG NV: the defensive gem that’s causing a stir in the balance sheets (and ruffling investors’ feathers a little)

1. Introduction & Overview

Brace yourself, we’re getting into the heavy stuff. CSG N.V. is a defence group based in Prague, in the Czech Republic, which operates in two sectors across Europe, the United States and the Asia-Pacific region, with clients ranging from NATO member defence ministries to major industrial companies in over 70 countries. Suffice to say that when geopolitics gets turbulent, CSG’s order book springs to life. Ammunition, armoured vehicles, military equipment: the company is riding the wave of post-2022 European rearmament, and its turnover has literally skyrocketed in recent years. But between hypergrowth, mounting debt and a share price that’s going up and down like a yo-yo, it’s worth getting the calculator out. Let’s get started.

2. Detailed Financial Analysis (marked out of 5)

📈 Turnover — 5/5

Turnover is set to rise from €620 million in 2020 to €6,741 million in 2025, representing an average annual growth rate of around 60 per cent over five years, with a surge of +71.8 per cent between 2024 and 2025 alone. It’s industrial madness. One caveat: the forecasts predict a marked slowdown (+11.3 per cent in 2026), a sign that the sprint is drawing to a close and giving way to a more sustainable pace.

💰 Net profit — 4/5

Net profit rises from €31.5 million (2020) to €694 million (2025), an impressive trajectory. However, the net margin falls slightly in 2025 (10.3 per cent compared with 13.4 per cent in 2024), weighed down by interest charges that have almost quintupled (–€344.6 million vs –€74.4 million). The 2026 forecasts (net margin ~15 per cent) indicate that profitability is expected to recover quickly.

🏦 Debt — 3/5

That’s a bit of a sticking point. Total debt to equity ratio at 2.63x, and, more importantly, a negative operating cash flow in 2025 (–€44.5 million), weighed down by a huge working capital requirement (–€1,702 million, typical of a company that loads its factories with stock and work in progress to fulfil its order book). The good news is that forecasts point to rapid deleveraging, with the company moving into negative net debt as early as 2028. One to watch, not one to avoid.

🎯 ROE — 5/5

A return on equity of 40.5 per cent in 2025, with a further 38.6 per cent expected in 2026. This is an exceptionally high level, even though the trend is towards a gradual return to normal (a target of 27.8 per cent in 2030). Shareholders clearly have nothing to complain about.

📊 Market performance — 4/5

TTM P/E ratio at 21.2x, falling to ~16.3x based on 2026 earnings and ~12.8x based on 2027 earnings: the valuation is falling rapidly as earnings grow. Morgan Stanley has initiated coverage with an ‘overweight’ recommendation and a target price of €42, more than double the current share price. However, the share price remains volatile: the share is trading within a 52-week range of €12.20 to €35.50, evidence of very real market jitters.

🏆 Overall average rating: 4.2/5

a solid growth engine, held back by still-high debt and a 2025 cash flow that needs to be monitored closely.

3. Outlook & Forecasts (2026–2027)

The projections paint a consistent picture: turnover of €7,502 million in 2026, rising to €8,745 million in 2027 (+16.6 per cent), net profit of €1,139 million, rising to €1,437 million, steadily increasing EBITDA, and, above all, accelerating debt reduction. In short, the company is consolidating its growth rather than chasing unsustainable figures.

Price estimate:

  • End of 2026: applying a target P/E ratio of 18–20x to the expected 2026 EPS (€1.086), this puts the share price at around €19.5 to €21.7.
  • End of 2027: with a normalised P/E ratio of 16–18x based on the 2027 EPS (€1.382), the target range is more likely to be €22 to €25.

This is more conservative than Morgan Stanley’s target of €42, but it still offers double-digit upside potential if the market narrative settles down.

4. Sector Analysis (Aerospace & Defence)

Key strengths

  • Structural European rearmament post-2022, sustained growth in NATO budgets
  • Multi-year order books, strong visibility on future revenues
  • High barriers to entry (certifications, sovereign contracts) = protected margins
  • Highly diversified customer base spanning more than 70 countries

Weaknesses

  • Long contract cycles = huge working capital requirements and irregular cash flow
  • High dependence on political and budgetary decisions
  • Regulatory risk (arms export licences, embargoes)
  • Sector excluded from many ESG funds, high stock market volatility (the share price has fallen by more than 50 per cent from its annual highs)

6. Conclusion

CSG NV is a company that has done the hard part: turning a surge in orders into a real cash cow (soon). Growth is slowing, but it is stabilising at a healthy pace; return on equity is excellent; and the current valuation, following the share price correction, leaves room for a pleasant surprise. The real area for vigilance is debt and cash burn linked to working capital requirements — not a deal-breaker in this sector, but something to monitor quarter by quarter. My honest opinion: this is a high-quality growth stock, not to be overlooked, but one to build up gradually rather than going all-in. Not a sure-fire winner, nor a smooth sailing ride — a stock for investors with nerves of steel.

  • Signal : Buy
  • Budget/Investment : Medium/High
  • Reinforcement required : No
  • Exposure : Low/Medium
  • Horizon : 1 to 2 years
  • Potential profitability : +37% to +56%
  • Ref. ISIN code : NL0015073TS8